<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pone.0171124.t002" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0171124.t002</object-id>
 <label>Table 2</label>
 <caption>
  <title>Prevalence of TDR in selected regions of East Africa.</title>
 </caption>
 <alternatives>
  <graphic id="pone.0171124.t002g" xlink:href="pone.0171124.t002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="center" rowspan="1" colspan="1">Country</th>
     <th align="center" rowspan="1" colspan="1">Region</th>
     <th align="center" rowspan="1" colspan="1">TDR Prevalence (%)</th>
     <th align="center" rowspan="1" colspan="1">Year(s) of Assessment</th>
     <th align="center" rowspan="1" colspan="1">HIV-1 TDR Eligibility among ARV-Naïve Persons</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">
      <bold>Kenya</bold>
     </td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Nairobi</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">7.5</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">2005</td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">HIV-infected persons aged ≥18 years who presented themselves for treatment at a clinic. No history of ARV use by self-report [
      <xref rid="pone.0171124.ref032" ref-type="bibr">32</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" rowspan="1" colspan="1">
      <bold>Kenya</bold>
     </td>
     <td align="justify" rowspan="1" colspan="1">Nairobi</td>
     <td align="center" rowspan="1" colspan="1">4.5</td>
     <td align="center" rowspan="1" colspan="1">2007/09</td>
     <td align="justify" rowspan="1" colspan="1">HIV-infected persons aged ≥18 years, eligible to start first-line ARV therapy in accordance with the treatment guidelines. All pregnant women were excluded [
      <xref rid="pone.0171124.ref027" ref-type="bibr">27</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">
      <bold>Kenya</bold>
     </td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Mombasa</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">4.9</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">2007/09</td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">HIV-infected persons aged ≥18 years, eligible to start first-line ARV therapy in accordance with the treatment guidelines. All pregnant women were excluded [
      <xref rid="pone.0171124.ref027" ref-type="bibr">27</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" rowspan="1" colspan="1">
      <bold>Kenya</bold>
     </td>
     <td align="justify" rowspan="1" colspan="1">Mombasa</td>
     <td align="center" rowspan="1" colspan="1">13.2</td>
     <td align="center" rowspan="1" colspan="1">2009/10</td>
     <td align="justify" rowspan="1" colspan="1">Newly diagnosed HIV-infected persons aged 18–25 years, or laboratory evidence of HIV recency (defined by a positive antibody test with a negative antibody test in the past 1 year, or an indeterminate/negative antibody test with detectable HIV RNA or p24 antigen) [
      <xref rid="pone.0171124.ref026" ref-type="bibr">26</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">
      <bold>Kenya</bold>
     </td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Kilifi</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">1.1</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">2008/10</td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Cross-sectional pretreatment HIVDR assessment from HIV-infected persons aged &gt;15 years [
      <xref rid="pone.0171124.ref016" ref-type="bibr">16</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" rowspan="1" colspan="1">
      <bold>Kenya</bold>
     </td>
     <td align="justify" rowspan="1" colspan="1">
      <bold>Ndhiwa</bold>
     </td>
     <td align="center" rowspan="1" colspan="1">
      <bold>9.2</bold>
     </td>
     <td align="center" rowspan="1" colspan="1">
      <bold>2012</bold>
     </td>
     <td align="justify" rowspan="1" colspan="1">See our 
      <bold>
       <xref ref-type="sec" rid="sec002">Methods</xref>
      </bold> section: Subsections–Study design and population, and HIV Status [
      <xref rid="pone.0171124.ref037" ref-type="bibr">37</xref>] and duration of recency.
     </td>
    </tr>
    <tr>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">
      <bold>Tanzania</bold>
     </td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Dar es Salaam</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">&lt;5.0</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">2005/06</td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">HIV-infected primagravidas aged &lt;25 years in the HIV sentinel surveillance among pregnant women attending antenatal clinic [
      <xref rid="pone.0171124.ref028" ref-type="bibr">28</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" rowspan="1" colspan="1">
      <bold>Uganda</bold>
     </td>
     <td align="justify" rowspan="1" colspan="1">Kampala</td>
     <td align="center" rowspan="1" colspan="1">7.0</td>
     <td align="center" rowspan="1" colspan="1">2002/04</td>
     <td align="justify" rowspan="1" colspan="1">HIV-infected persons from a HIV RNA monitoring study. No history of ARV use by self-report [
      <xref rid="pone.0171124.ref029" ref-type="bibr">29</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">
      <bold>Uganda</bold>
     </td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Entebbe</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">0.0</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">2006/07</td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">HIV-infected primagravidas aged 13–22 years with no previous positive HIV test, and ≥500 CD4 cell count (cells/mL) [
      <xref rid="pone.0171124.ref033" ref-type="bibr">33</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" rowspan="1" colspan="1">
      <bold>Uganda</bold>
     </td>
     <td align="justify" rowspan="1" colspan="1">Entebbe</td>
     <td align="center" rowspan="1" colspan="1">19.2</td>
     <td align="center" rowspan="1" colspan="1">2006/09</td>
     <td align="justify" rowspan="1" colspan="1">Incident cases: Persons that seroconverted during 1- or 3-month. Persons (including women in antenatal care) not followed in the HIV incidence studies but had documentations of a previous HIV-negative test results were also eligible. HIV recency defined by a positive antibody test with a negative antibody test in the past 1 year, or an indeterminate/negative antibody test with detectable HIV RNA or p24 antigen) [
      <xref rid="pone.0171124.ref010" ref-type="bibr">10</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">
      <bold>Uganda</bold>
     </td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Mbarara</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">3.0</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">2005/10</td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">HIV-infected persons from a HIV RNA monitoring study. No history of ARV use by self-report [
      <xref rid="pone.0171124.ref029" ref-type="bibr">29</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" rowspan="1" colspan="1">
      <bold>Uganda</bold>
     </td>
     <td align="justify" rowspan="1" colspan="1">Southwestern Uganda</td>
     <td align="center" rowspan="1" colspan="1">1.4</td>
     <td align="center" rowspan="1" colspan="1">2004/10</td>
     <td align="justify" rowspan="1" colspan="1">Incident cases: Persons that seroconverted during 3-month follow-up for 6 years and their CD4 cell count results were available. Estimated date of seroconversion was the midpoint between the last seronegative (antibody-negative test result) date and the first seropositive (antibody-positive test result) date [
      <xref rid="pone.0171124.ref031" ref-type="bibr">31</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">
      <bold>Uganda</bold>
     </td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Kampala</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">8.6</td>
     <td align="center" style="background-color:#C0C0C0" rowspan="1" colspan="1">2009/10</td>
     <td align="justify" style="background-color:#C0C0C0" rowspan="1" colspan="1">Newly diagnosed persons aged 18–25 years voluntary counseling and testing centers, or laboratory evidence of HIV recency (defined by a positive antibody test with a negative antibody test in the past 1 year, or an indeterminate/negative antibody test with detectable HIV RNA or p24 antigen) [
      <xref rid="pone.0171124.ref011" ref-type="bibr">11</xref>].
     </td>
    </tr>
    <tr>
     <td align="justify" rowspan="1" colspan="1">
      <bold>Uganda</bold>
     </td>
     <td align="justify" rowspan="1" colspan="1">Masaka, Wakiso, Mukono</td>
     <td align="center" rowspan="1" colspan="1">6.4</td>
     <td align="center" rowspan="1" colspan="1">2009/11</td>
     <td align="justify" rowspan="1" colspan="1">Incident cases: Persons with high-risk behaviour who seroconverted during 6-month follow-up for 2 years. Estimated date of seroconversion was the midpoint between the last seronegative date and the first seropositive date [
      <xref rid="pone.0171124.ref030" ref-type="bibr">30</xref>].
     </td>
    </tr>
   </tbody>
  </table>
 </alternatives>
</table-wrap>
